PKB/Akt1 is a central regulator of cellular processes:
Insulin and Growth Factor Signaling:
DNA Damage Response:
Apoptosis Regulation:
Activators: Compounds like FTY720 (a sphingosine-like analogue) activate Pak1 (a related kinase) to protect against cardiac hypertrophy , though PKB/Akt1-specific activators remain under development.
Inhibitors: Covalent and non-covalent inhibitors are being explored for cancer treatment, though off-target effects pose challenges .
Tissue-Specific Targeting:
Therapeutic Development:
The recombinant form of Protein Kinase Akt1 is a glycosylated polypeptide with a molecular mass of approximately 59.1 kDa. It is fused with a polyhistidine tag at the N-terminus to facilitate the removal of Akt1 kinase from the reaction mixture . This recombinant enzyme is typically produced in Sf9 insect cells and is purified using proprietary chromatographic techniques .
Akt1 is involved in several critical cellular pathways: